Shanhe Li

1.0k total citations
37 papers, 766 citations indexed

About

Shanhe Li is a scholar working on Oncology, Molecular Biology and Biomaterials. According to data from OpenAlex, Shanhe Li has authored 37 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Molecular Biology and 11 papers in Biomaterials. Recurrent topics in Shanhe Li's work include Metal complexes synthesis and properties (15 papers), Nanoparticle-Based Drug Delivery (11 papers) and Nanoplatforms for cancer theranostics (7 papers). Shanhe Li is often cited by papers focused on Metal complexes synthesis and properties (15 papers), Nanoparticle-Based Drug Delivery (11 papers) and Nanoplatforms for cancer theranostics (7 papers). Shanhe Li collaborates with scholars based in China, United States and Macao. Shanhe Li's co-authors include Feng Yang, Zhenlei Zhang, Gang Xu, Hong Liang, Juzheng Zhang, Hong Liang, Hongbin Sun, Wenjuan Li, Yan Zhao and Ming Jiang and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Advanced Functional Materials.

In The Last Decade

Shanhe Li

36 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanhe Li China 18 350 270 179 172 143 37 766
Ada W.Y. Leung Canada 17 275 0.8× 300 1.1× 174 1.0× 95 0.6× 137 1.0× 30 720
Paul Cressey United Kingdom 12 266 0.8× 170 0.6× 170 0.9× 131 0.8× 95 0.7× 21 515
Zhenlei Zhang China 21 563 1.6× 299 1.1× 322 1.8× 112 0.7× 163 1.1× 36 902
Dongfan Song China 18 353 1.0× 390 1.4× 193 1.1× 221 1.3× 91 0.6× 32 910
Carmen A. Widmer Switzerland 3 320 0.9× 318 1.2× 127 0.7× 122 0.7× 95 0.7× 3 698
Bernhard Englinger Austria 14 273 0.8× 304 1.1× 166 0.9× 79 0.5× 61 0.4× 28 699
Bhabatosh Banik India 16 366 1.0× 265 1.0× 261 1.5× 155 0.9× 122 0.9× 24 845
Raymond Wai‐Yin Sun China 14 519 1.5× 247 0.9× 403 2.3× 110 0.6× 104 0.7× 15 964
Steffen Daum Germany 12 291 0.8× 272 1.0× 365 2.0× 166 1.0× 50 0.3× 18 693
Kushtrim Kryeziu Austria 15 412 1.2× 344 1.3× 185 1.0× 61 0.4× 62 0.4× 25 846

Countries citing papers authored by Shanhe Li

Since Specialization
Citations

This map shows the geographic impact of Shanhe Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanhe Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanhe Li more than expected).

Fields of papers citing papers by Shanhe Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanhe Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanhe Li. The network helps show where Shanhe Li may publish in the future.

Co-authorship network of co-authors of Shanhe Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shanhe Li. A scholar is included among the top collaborators of Shanhe Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanhe Li. Shanhe Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shanhe, et al.. (2025). Development of a theranostic tri-nuclear gadolinium(III) complex based on apoferritin for multitarget therapy of orthotopic glioma. Chinese Journal of Structural Chemistry. 44(11). 100711–100711. 1 indexed citations
2.
Zhou, Yiqi, Yanyan Song, Tian Qi, et al.. (2025). Nanozymes - A new opportunity for the treatment of neurodegenerative diseases. Chemical Engineering Journal. 525. 169965–169965.
3.
Zhu, Minghui, Shanhe Li, Wenjuan Li, et al.. (2025). Design of a theranostic Gd (III)–Cu (I) complex to inhibit growth and metastasis of triple‐negative breast cancer. Rare Metals. 44(4). 2589–2604. 8 indexed citations
4.
Li, Shanhe, et al.. (2024). Ferroptosis-inducing nanocomposite hydrogels: A multimodal platform for enhanced cancer therapeutics. Chemical Engineering Journal. 500. 157451–157451. 3 indexed citations
5.
Pang, Jinhui, Yong Kyu Chu, Shanhe Li, et al.. (2024). In vitro and In vivo anticancer activities of Bi(III) 2-thiazolecarboxaldehyde thiosemicarbazone complex. Journal of Molecular Structure. 1318. 139389–139389. 3 indexed citations
6.
Li, Wenjuan, Shanhe Li, Gang Xu, et al.. (2024). A novel Au(III) agent designed to inhibit tumor growth and metastasis through inducing immunogenic cell death. Rare Metals. 44(1). 430–443. 12 indexed citations
7.
Li, Wenjuan, Shanhe Li, Gang Xu, et al.. (2024). Anticancer Tetranuclear Cu(I) Complex Catalyzes a Click Reaction to Synthesize a Chemotherapeutic Agent in situ to Achieve Targeted Dual‐Agent Combination Therapy for Cancer. Angewandte Chemie International Edition. 63(51). e202411846–e202411846. 17 indexed citations
8.
9.
Li, Wenjuan, Shanhe Li, Gang Xu, et al.. (2024). Developing a Rhodium(III) Complex to Reprogram the Tumor Immune and Metabolic Microenvironments: Overcoming Multidrug Resistance and Metastasis in Non-Small Cell Lung Cancer. Journal of Medicinal Chemistry. 67(19). 17243–17258. 14 indexed citations
10.
Li, Shanhe, et al.. (2024). Hydrogel in the Treatment of Traumatic Brain Injury. Biomaterials Research. 28. 85–85. 7 indexed citations
11.
12.
Wang, Xiaojun, et al.. (2023). Novel mono-, bi-, tri- and tetra-nuclear copper complexes that inhibit tumor growth through apoptosis and anti-angiogenesis. Journal of Inorganic Biochemistry. 250. 112403–112403. 15 indexed citations
13.
Zhang, Zhenlei, Juzheng Zhang, Wenjuan Li, et al.. (2022). Developing a Novel Indium(III) Agent Based on Human Serum Albumin Nanoparticles: Integrating Bioimaging and Therapy. Journal of Medicinal Chemistry. 65(7). 5392–5406. 26 indexed citations
14.
Liu, Xiao, Ting Zhang, Ziyang Tan, et al.. (2022). A Hashing-Based Framework for Enhancing Cluster Delineation of High-Dimensional Single-Cell Profiles. PubMed. 2(5). 323–335. 7 indexed citations
15.
Abdulla, Aynur, Ting Zhang, Shanhe Li, et al.. (2022). Integrated microfluidic single-cell immunoblotting chip enables high-throughput isolation, enrichment and direct protein analysis of circulating tumor cells. Microsystems & Nanoengineering. 8(1). 13–13. 37 indexed citations
16.
Gou, Yi, Meirong Chen, Shanhe Li, et al.. (2021). Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer. Journal of Medicinal Chemistry. 64(9). 5485–5499. 69 indexed citations
17.
Jiang, Ming, Shanhe Li, Wenjuan Li, et al.. (2020). Designing biotin-human serum albumin nanoparticles to enhance the targeting ability of binuclear ruthenium(III) compound. Journal of Inorganic Biochemistry. 215. 111318–111318. 9 indexed citations
18.
Zhang, Zhenlei, Juzheng Zhang, Ming Jiang, et al.. (2020). Human Serum Albumin-Based Dual-Agent Delivery Systems for Combination Therapy: Acting against Cancer Cells and Inhibiting Neovascularization in the Tumor Microenvironment. Molecular Pharmaceutics. 17(4). 1405–1414. 23 indexed citations
19.
Li, Shanhe, Zhenlei Zhang, Juzheng Zhang, et al.. (2019). Developing a binuclear multi-target Bi(III) complex by optimizing 2-acetyl-3-ethylpyrazine thiosemicarbazides. European Journal of Medicinal Chemistry. 182. 111616–111616. 19 indexed citations
20.
Lin, Xiaotong, Yan Zhao, & Shanhe Li. (2017). Astaxanthin attenuates glutamate-induced apoptosis via inhibition of calcium influx and endoplasmic reticulum stress. European Journal of Pharmacology. 806. 43–51. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ada W.Y. Leung Breakdown of academic impact, for papers by Paul Cressey Breakdown of academic impact, for papers by Zhenlei Zhang Breakdown of academic impact, for papers by Dongfan Song Breakdown of academic impact, for papers by Carmen A. Widmer Breakdown of academic impact, for papers by Bernhard Englinger Breakdown of academic impact, for papers by Bhabatosh Banik Breakdown of academic impact, for papers by Raymond Wai‐Yin Sun Breakdown of academic impact, for papers by Steffen Daum Breakdown of academic impact, for papers by Kushtrim Kryeziu
Rankless by CCL
2026